MedPath

The Impact of Radiation on Serum Anti-Mullerian Hormone during Hysterosalpingography

Recruiting
Conditions
Ovarian reserve evaluating by serum anti-mullerian hormone in infertile women requiring hysterosalpingography
AMH, Anti-Mullerian hormone, hysterosalpingography, ovarian reserve, radiation
Registration Number
TCTR20210329005
Lead Sponsor
Faculty of Medicine, Prince of Songkla University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
76
Inclusion Criteria

1. Thai women aged 25-40 years diagnosed with infertile requiring hysterosalpingography as initial investigation
2. Regular menstrual cycle with a mean length ranging between 24-38 days
3. Body mass index 18.5-24.9 kg/m2

Exclusion Criteria

1. Polycystic ovarian syndrome diagnosed by Rotterdam criteria 2003
2. No history of adnexa surgery
3. No history of chemotherapy
4. No history of radiotherapy
5. No history of pelvic radiograph
6. No current smoking
7. No hormonal use within the last 3 months

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in serum antimullerian hormone level At enrollment, 1 month and 3 months Serum antimullerian hormone by ELISA generation II
Secondary Outcome Measures
NameTimeMethod
/A N/A N/A
© Copyright 2025. All Rights Reserved by MedPath